Wednesday, 27 October 2021


ADB approves $450 M loan to help Indonesia deliver effective COVID-19 vaccines

05 April 2021 | News

The Responsive COVID-19 Vaccines for Recovery (RECOVER) project will fund the purchase of at least 65 million doses

The Asian Development Bank (ADB) has approved a $450 million loan to Indonesia to help Bio Farma, a state-owned vaccine supplier, procure and deliver safe and effective vaccines against the coronavirus disease (COVID-19).

The Responsive COVID-19 Vaccines for Recovery (RECOVER) project will fund the purchase of at least 65 million doses of COVID-19 vaccine for priority groups determined by the Indonesian government.

The project is supported by ADB’s $9 billion Asia Pacific Vaccine Access Facility (APVAX), which was launched in December 2020 to offer rapid and equitable vaccine-related support to ADB developing members.

The Indonesian government aims to vaccinate 181.5 million people against COVID-19 in one of the world’s biggest vaccination campaigns. Indonesia recorded more than 1.5 million COVID-19 cases and 40,000 deaths as of 30 March.

The RECOVER project follows earlier ADB assistance to help Indonesia address the challenges posed by the pandemic. This includes a $3 million Asia Pacific Disaster Response Fund grant approved in April 2020 to help the Ministry of Health deliver critical medical equipment and supplies; and a $1.5 billion COVID-19 Active Response and Expenditure (CARES) Program loan as budget support for urgent public health, social, and economic assistance.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account